Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
New Workers' Compensation Review Contractor
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
News Release
Stone Point Capital Completes Acquisition of Genex Services from Funds Advised by Apax Partners
Wayne, PA – March 9, 2018 – Genex Services (“Genex”), a leading
Mitchell
News Release
Oklahoma House Committee Advances Workers' Compensation Reform Legislation
By Brian Allen, VP of Government Affairs
Disability
Article
ABCs of the ADAAA: Are You Compliant?
Tom Kerr (TK): I’m Tom Kerr.
Workers' Comp
Article
StateWatch: Bill Review March 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
Indiana Legislature Passes Drug Formulary Bill
By Brian Allen, VP of Government Affairs